MARINUS PHARMACEUTICALS INC (MRNS) Institutional Ownership
None of the superinvestors we track currently report MARINUS PHARMACEUTICALS INC (MRNS) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in MARINUS PHARMACEUTICALS INC (MRNS), this page will show 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2024 | 1 | $883,399 | 501,931 |
| Q2 2024 | 1 | $727,301 | 621,625 |
| Q2 2023 | 1 | $680 | 62,600 |
| Q1 2023 | 1 | $906 | 131,300 |
| Q4 2022 | 1 | $648 | 162,700 |
| Q3 2022 | 1 | $1,286 | 193,325 |
| Q2 2022 | 1 | $759 | 156,900 |
| Q1 2022 | 1 | $317 | 33,900 |
| Q2 2021 | 1 | $11,213 | 625,000 |
| Q1 2021 | 1 | $4,602 | 297,272 |
Related MRNS Institutional Insights:
- MRNS Institutional Ownership & Insiders Activity
- MRNS Institutional Ownership & 13F Activity
- MRNS Top Institutional Shareholders
- MRNS Institutional Buying Activity
- MRNS Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- MRNS Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings